Physician profile
John A Hoehn
NPI 1891755690
$1,562.99
in general payments reported to CMS, 2019-2025
24 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $631 · 2020: $183 · 2021: $164 · 2022: $87.94 · 2023: $63.48 · 2024: $283 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $496.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $606.87 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Allergan, INC. | $164.55 | 2019 | |
| Sanofi-Aventis U.S. LLC | $139.00 | 2019 | |
| Abbvie INC. | $80.95 | 2019-2025 | |
| Amgen INC. | $76.75 | 2019 | |
| Mylan Specialty L.P. | $56.83 | 2019-2024 | Yupelri |
| Abbott Laboratories | $52.82 | 2019-2024 | Freestyle Libre 3 |
| Lilly USA, LLC | $38.43 | 2024 | Jardiance |
| Inspire Medical Systems, INC. | $38.34 | 2025 | Inspire |
| Pfizer INC. | $31.63 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $28.98 | 2019-2024 | |
| Axsome Therapeutics, INC. | $26.73 | 2025 | Auvelity |
| Tactile Systems Technology INC | $26.61 | 2024 | Entre Plus, Flexitouch Plus |
| Jazz Pharmaceuticals INC. | $24.80 | 2019 | |
| Almatica Pharma LLC | $24.69 | 2024 | Loreev Xr |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $24.34 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.82 | 2019 | |
| Astellas Pharma US INC | $17.80 | 2024 | Veozah |
| Echosens North America, INC. | $16.05 | 2024 | Fibroscan |
| Sun Pharmaceutical Industries INC. | $13.80 | 2021 | |
| Sanofi Pasteur INC. | $13.47 | 2019 | |
| Horizon Therapeutics Plc | $13.45 | 2020 | |
| Ethicon US, LLC | $12.37 | 2019 | |
| Sunovion Pharmaceuticals INC. | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hoehn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.